Keith Hoffman is a seasoned business and corporate executive with over 22 years of expertise in intellectual property development, healthcare data, biotechnology, medical devices, and consumer products. He holds a Ph.D. in Neuropharmacology from the renowned lab of Dr. Gary Lynch at the University of California, Irvine, and has authored 30 academic publications across various scientific disciplines.

With experience as a Chief Business Officer at Athos Therapeutics Inc and a former Senior Vice President of Business Development and Technology Transfer at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Keith has a proven track record of generating, negotiating, and managing partnerships and collaborations across therapeutic areas. He has also drafted over 70 patent applications and raised over $60MM in Series A, B, C, and PIPEs as a key player in equity investing.

Keith’s expertise includes business development, funding, corporate development, licensing, intellectual property, scientific research, and investing. He has also authored 20 white/position papers, developed an extensive deal sheet that includes financings, licensing, sponsored research, sales and marketing, royalty monetization, collaborations, mergers, and patent litigation.